Product Images Nivestym

The text contains only two fragments of text which are not enough to provide a useful description. The first fragment includes the characters "P zer" and the second fragment includes the word "Oncology". Without further context, it is not possible to generate a description or to infer what the text is referring to.*

Not available.*

This text describes an alcohol wipe cotton ball, an adhesive bandage, and a sharps disposal container, likely related to medical or first aid use.*

This appears to be a list of body parts including the stomach area, thigh, upper arm, and buttocks.*

The text describes a disposable syringe that has a plunger.*

This is a list of body parts: Upper arm, abdomen, buttocks, and thigh.*

This text is not clear and cannot be evaluated without more context.*

Nivestym is a prescription drug that comes in a 1 mL single-dose vial. It contains filgrastim-aafi and is distributed by Pfizer Labs, a division of Pfizer Inc. It is recommended to store the medication at 2°C to 8°C. The dosage information can be found on the package. The drug is produced by Hospira, Inc. and is a biosimilar. The US License number for this medication is 1974.*

Nivestym is a medication that comes in the form of an injection with no preservatives. The provided text also contains various identification numbers, possibly for inventory or tracking purposes, and some illegible characters.*

This is a medication called Nivestym (filgrastim-aafi) Injection that is manufactured by Hospira, Inc. The dosage instructions are on the package. It is important to store it at 2°08°C. The medication comes in a 1.6 mL single-dose vial and is distributed by Pfizer Labs. This medication is a biosimilar. The text includes a reference number of RL10065.*

This text describes a medication called 'filgrastim-aafi' which is sold as a single dose in a syringe. It is for subcutaneous use only and produced by the company 'Hospialnc'. The medication has a concentration of 300mg/0.5mL and comes in a BTV container. The text includes a license number and a production date but does not include any information on the medical uses or side effects of the medication.*

This appears to be a product description for a single-dose prefilled syringe with a needle guard. The syringe contains a sterile solution with recombinant Granulocyte Colony Stimulating factor (G-CSF) derived from E. coli. It is for subcutaneous use only and should be discarded if unused. The product is called ivestym™ (filgrastim-aafi) Injection and comes in a 300 mogh.5ml dose.*

This appears to be the label or packaging information for a medication called "Neulastim" or "Filgrastim-aafi" for subcutaneous use only. It includes the manufacturer's name and license number, as well as production and expiration information, but does not provide information on the medication's purpose or effects.*

Nivestym is a sterile solution injection of 480 mcg/0.8 mL Filgrastim-aafi, a recombinant Granulocyte Colony Stimulating Factor derived from E. coli, for subcutaneous use only. It is a single-dose prefilled syringe with needle guard. The unused portion should be discarded, and the solution has no preservative.*

This appears to be a mixture of outputs and does not make a coherent description. The text does not appear to be readable and may need to be rescanned or checked for any errors during transcription.*